XRHealth has demonstrated significant impact through their evidence-based treatment approaches that combine cutting-edge XR technology with clinical therapies including cognitive behavioral therapy (CBT) and biopsychosocial protocols. Their platform serves multiple audiences including physical therapists, occupational therapists, and mental health professionals. According to research studies, their VR solutions for pain management have shown significant reduction in pain for acute inpatient settings and for at-home chronic pain treatment, potentially offering an effective alternative to prescription opioids. Patients report improved range of motion, better focus, and faster progress toward wellness goals when using XRHealth's therapeutic solutions.

XRHealth's platform is accessible through VR/AR headsets including Quest and Apple Vision devices, allowing patients to access therapeutic sessions from the comfort of their homes. The company operates its own clinics and collaborates with healthcare organizations worldwide, enabling seamless integration of XR therapies into diverse clinical settings. They have received recognition in the healthcare industry, including being selected to deploy their solution in every police station throughout Israel to promote mental health resilience among officers. In 2023, they acquired Amelia Virtual Care and NeuroReality, and in 2025, they acquired RealizedCare, further expanding their therapeutic platform and establishing themselves as the largest AI-driven therapeutic XR platform globally.